top
Search terms
Results 61 - 70 of 130 - ordered by :
Pages: 1 ... 4 5 6 7 8 9 10 ... 13
Epeuropace

Over time many stroke risk stratification schema have been developed, initially with the objective to better define high-risk patients who could be subjected to an inconvenient (and potentially ...

Europace, Editorial, Ron Pisters, Jonas B. Olesen, Gregory Y.H. Lip

Date : 01/01/2012 Item size : 140103 bytes
Epeuropace

The fear of bleeding among physicians leads to lack of prescription of oral anticoagulants, and reduces uptake, in patients who may otherwise benefit from them.1,2 Stroke risk is closely related to ...

Europace, Editorial, Pilar Gallego, Gregory Y. H. Lip, Deirdre A. Lane

Date : 01/06/2013 Item size : 150506 bytes
Epeuropace

Discussing heart rate turbulence and microvolt T-wave alternans in patients after myocardial infarction: In response to his question about our patient series, all consecutive patients who were ...

EP Europace, Letter to the Editor, Vitaly Sulimov, Elena Okisheva, Dmitry Tsaregorodtsev

Date : 01/01/2013 Item size : 104062 bytes
Ehjcardiovascrec

Abstract Objective: The cardiac ankyrin repeat protein (CARP), a nuclear transcription co-factor that negatively regulates cardiac gene expression, is increased in human heart failure and in animal ...

Cardiovascular Research, Original Article, Oliver Zolk, Michael Marx, Elmar Jäckel, Ali El-Armouche, Thomas Eschenhagen

Date : 01/09/2003 Item size : 258892 bytes
Ehjcardiovascrec

To this end cRNA encoding the human Na+ channel SCN5A was injected into Xenopus laevis oocytes with or without cRNA encoding the wild-type kinases SGK1, the constitutively active kinase S422DSGK1, ...

Cardiovascular Research, Original Article, Christoph Boehmer, Viktoria Wilhelm, Monica Palmada, Sabine Wallisch, Guido Henke, Heinrich Brinkmeier, Philip Cohen, Burkert Pieske, Florian Lang

Date : 15/03/2003 Item size : 248957 bytes
Ehjcardiovascrec

Keywordsβ2-adrenergic agonistHypertrophyRat, ventricleTime for primary review 31 days. 1 Introduction Previous studies have shown that different stimuli induce cardiac hypertrophy in animals with ...

Cardiovascular Research, Original Article, Kit Wong, Kenneth R Boheler, Jill Bishop, Mario Petrou, Magdi H Yacoub

Date : 01/01/1998 Item size : 264423 bytes
Epeuropace

Numerous risk factors pre-dispose to atrial fibrillation (AF), namely, hypertension, heart failure, increasing age, diabetes mellitus, and vascular disease.1 Due to the ageing population and the ...

Europace, Editorial, Jonas Bjerring Olesen, Gregory Y.H. Lip, Deirdre A. Lane

Date : 01/08/2011
Epeuropace

For adequate stroke prevention, most patients with non-valvular atrial fibrillation (AF) would need oral anticoagulant therapy (OAC), with either vitamin-K antagonists (VKAs) or non-vitamin-K oral ...

Europace, Editorial, Tatjana S. Potpara, Deirdre A. Lane, Gregory Y.H. Lip

Date : 01/04/2015
Epeuropace

Atrial fibrillation (AF) is the commonest cardiac rhythm disorder and is associated with an increased risk of mortality and morbidity from stroke and thromboembolism. Several NOACs now exist, ...

Europace, Editorial, Torben Bjerregaard Larsen

Date : 01/02/2015